Last updated on August 2011

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer


Brief description of study

RATIONALE: Anticoagulants, such as dalteparin, may help prevent blood clots from forming in patients with lung cancer. It is not yet known whether dalteparin is effective in preventing blood clots in patients with lung cancer. PURPOSE: This randomized phase III trial is studying how well dalteparin works in preventing blood clots in patients with lung cancer.

Detailed Study Description

OBJECTIVES: Primary - Determine whether the addition of dalteparin results in improved survival. Secondary - Determine venous thrombotic event-free survival and metastasis-free survival. - Determine serious adverse events in patients treated with this drug. - Determine the toxicity of this drug in these patients. - Determine the quality of life, breathlessness, anxiety, and depression in patients treated with this drug. - Determine the cost effectiveness and cost utility of this drug. OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms. - Arm I (control): Patients receive anticancer treatment considered appropriate by the local medical team. - Arm II: Patients receive anticancer treatment considered appropriate by the local medical team. Beginning before the start of the first definitive anticancer treatment, patients receive dalteparin subcutaneously daily for up to 24 weeks. Quality of life, anxiety, depression, and dyspnea are assessed at baseline, at 12 and 24 weeks, and then at 9 and 12 months. After completion of therapy, patients are followed at 9 months, 1 year, and then every 6 months for at least 2 years.

Clinical Study Identifier: NCT00519805

Find a site near you

Start Over

Blackpool Victoria Hospital

Blackpool, United Kingdom
  Connect »

Stoke Mandeville Hospital

Aylesbury-Buckinghamshire, United Kingdom
  Connect »

Furness General Hospital

Barrow in Furness, United Kingdom
  Connect »

Royal Blackburn Hospital

Blackburn, United Kingdom
  Connect »

Royal Bournemouth Hospital

Bournemouth, United Kingdom
  Connect »

Burnley General Hospital

Burnley, United Kingdom
  Connect »

Queen's Hospital

Burton-upon-Trent, United Kingdom
  Connect »

West Suffolk Hospital

Bury St. Edmunds, United Kingdom
  Connect »

Walsgrave Hospital

Coventry, United Kingdom
  Connect »

Darlington Memorial

Darlington, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.